February 9, 2026
Meet Irma Mahmutovic Persson - In Vivo Imaging Specialist at LBIC
In this edition of our Meet the Nodes interview series, we introduce Irma Mahmutovic Persson, staff researcher at the Lund BioImaging Centre (LBIC),…
Euro-BioImaging is thrilled to welcome the Kingdom of Spain and the Kingdom of Belgium as its newest member countries. Both membership requests were approved by our Board on December 13, 2023. We are delighted to welcome these two new member states, signifantly expanding imaging horizons in Europe.
As official member countries, Spain and Belgium will not only contribute their delegates to the Euro-BioImaging Board but also play key roles in shaping European imaging strategies and influencing research trends. Their involvement is expected to bring valuable insights and directions to key issues, significantly impacting the future of imaging research infrastructures across Europe and beyond. Spain and Belgium will also be able to promote their national biological and biomedical imaging capabilities within the networks of our European organization. In addition, they will have the opportunity to host Euro-BioImaging Nodes, further integrating their expertise into our community. Their national capabilities and hosting Euro-BioImaging Nodes will enhance collaborative research and provide opportunities to advance scientific discoveries.
“The addition of Spain and Belgium to Euro-BioImaging, bringing our total membership to 19, is a remarkable milestone to conclude the year," comments Euro-BioImaging Director General, John Eriksson. "Their strong commitment and expertise in bioimaging align with our goals and also promise to enrich our community with invaluable insights and contributions to facilitate excellent science and innovation.”

February 9, 2026
In this edition of our Meet the Nodes interview series, we introduce Irma Mahmutovic Persson, staff researcher at the Lund BioImaging Centre (LBIC),…
February 3, 2026
There’s a new marine sample dataset on the BioImage Archive, thanks to Tina Wiegand and her colleagues, part…
February 3, 2026
Breast cancer remains one of the most common cancers worldwide, and HER2-positive tumours — characterised by overexpression of the HER2 receptor — are known…